Wu Tingting, Zhou Haijun, Xu Suling, Deng Zaichun, Zhang Yun, Ding Qunli
Department of Respiratory, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China.
Department of Respiratory, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China.
Am J Med Sci. 2023 May;365(5):429-436. doi: 10.1016/j.amjms.2022.12.001. Epub 2022 Dec 13.
This study retrospectively analyzed the laboratory data and chest images of patients with amyopathic dermatomyositis associated with interstitial lung disease (ADM-ILD) and patients with other connective tissue disease-related ILDs (CTD-ILDs) to find a characteristic index for the early recognition of ADM-ILD and help clinicians consider the possibility of ADM-ILD as soon as possible.
In our cohort study, the records of 128 Chinese patients with CTD-ILD, including 33 ADM-ILD patients, 37 rheumatoid arthritis (RA)-ILD patients, 33 primary Sjogren's syndrome (pSS)-ILD patients, 14 systemic sclerosis (SSc)-ILD patients and 11 systemic lupus erythematosus (SLE)-ILD patients. The patients' clinical features, laboratory parameters, and chest HRCT findings were analyzed.
ADM-ILD patients generally had significantly higher LDH (333.52±160.21 U/L), AST (66.21±83.66 U/L), and CK-MB (18.23±8.28 U/L) levels than other CTD-ILD patients. A total of 90.91% (30/33) of ADM-ILD patients had elevated LDH. Patients with ADM-ILD were more prone to organizing pneumonia radiologic patterns on chest HRCT scans than patients with other CTD-ILDs (χ=37.39, p < 0.001) and were found in 18 of 33 ADM-ILD patients. Anti-MDA5 (45.45%) was the most commonly detected autoantibody in ADM-ILD patients, followed by anti-PL-7 (21.21%), anti-Jo-1 (12.12%), and anti-PL-12 (9.09%), and levels of ALT (96.93±119.79 vs. 17.50±6.218 U/L), AST (113.00±106.13 vs. 23.56±6.91 U/L), LDH (415.00±198.51 vs. 261.94±67.75 U/L) and CK-MB (22.57±5.91 vs. 14.61±8.36 U/L) were significantly higher in anti-MDA5-positive patients, but these patients had significantly lower WBC counts (4.82±2.61 vs. 7.14±3.00 × 10/L), lymphocyte counts (0.72±0.20 vs. 1.23±0.53 × 10/L), and ALB levels (31.90±4.76 vs. 35.49±4.71 g/L).
ADM-ILD patients have higher serum LDH, AST and CK-MB levels, especially serum LDH levels, and are more prone to organizing pneumonia radiologic patterns on chest HRCT scans than other CTD-ILD patients. A high level of serum LDH with ILD may be a useful characteristic index for recognizing ADM-ILD.
本研究回顾性分析了合并间质性肺疾病的无肌病性皮肌炎(ADM-ILD)患者及其他结缔组织病相关间质性肺疾病(CTD-ILD)患者的实验室数据和胸部影像,以寻找早期识别ADM-ILD的特征性指标,帮助临床医生尽早考虑ADM-ILD的可能性。
在我们的队列研究中,纳入了128例中国CTD-ILD患者的记录,其中包括33例ADM-ILD患者、37例类风湿关节炎(RA)-ILD患者、33例原发性干燥综合征(pSS)-ILD患者、14例系统性硬化症(SSc)-ILD患者和11例系统性红斑狼疮(SLE)-ILD患者。分析了患者的临床特征、实验室参数和胸部高分辨率CT(HRCT)表现。
ADM-ILD患者的乳酸脱氢酶(LDH)(333.52±160.21 U/L)、谷草转氨酶(AST)(66.21±83.66 U/L)和肌酸激酶同工酶(CK-MB)(18.23±8.28 U/L)水平通常显著高于其他CTD-ILD患者。共有90.91%(30/33)的ADM-ILD患者LDH升高。与其他CTD-ILD患者相比,ADM-ILD患者在胸部HRCT扫描上更易出现机化性肺炎的影像学表现(χ=37.39,p<0.001),33例ADM-ILD患者中有18例出现此表现。抗黑色素瘤分化相关基因5(Anti-MDA5)(45.45%)是ADM-ILD患者中最常检测到的自身抗体,其次是抗PL-7(21.21%)、抗Jo-1(12.12%)和抗PL-12(9.09%),抗MDA5阳性患者的谷丙转氨酶(ALT)(96.93±119.79 vs. 17.50±6.218 U/L)、AST(113.00±106.13 vs. 23.56±6.91 U/L)、LDH(415.00±198.51 vs. 261.94±67.75 U/L)和CK-MB(22.57±5.91 vs. 14.61±8.36 U/L)水平显著更高,但这些患者的白细胞计数(4.82±2.61 vs. 7.14±3.00×10/L)、淋巴细胞计数(0.72±0.20 vs. 1.23±0.53×10/L)和白蛋白(ALB)水平(31.90±4.76 vs. 35.49±4.71 g/L)显著更低。
ADM-ILD患者的血清LDH、AST和CK-MB水平更高,尤其是血清LDH水平,并且与其他CTD-ILD患者相比,在胸部HRCT扫描上更易出现机化性肺炎的影像学表现。血清LDH水平升高合并ILD可能是识别ADM-ILD的有用特征性指标。